IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BORGHI, MARIA ORIETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.031
NA - Nord America 6.589
AS - Asia 6.514
SA - Sud America 641
AF - Africa 136
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.946
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.165
CN - Cina 2.268
SG - Singapore 1.957
GB - Regno Unito 1.581
IT - Italia 1.345
DE - Germania 1.122
HK - Hong Kong 611
SE - Svezia 561
RU - Federazione Russa 485
BR - Brasile 454
FR - Francia 413
ES - Italia 384
VN - Vietnam 371
CA - Canada 312
IN - India 252
BD - Bangladesh 248
NL - Olanda 229
TR - Turchia 171
IE - Irlanda 169
FI - Finlandia 155
KR - Corea 154
JP - Giappone 147
UA - Ucraina 140
ID - Indonesia 76
MX - Messico 73
EU - Europa 63
BE - Belgio 60
CO - Colombia 58
GR - Grecia 56
PL - Polonia 54
CH - Svizzera 52
DK - Danimarca 52
AR - Argentina 50
CI - Costa d'Avorio 47
PH - Filippine 31
TW - Taiwan 30
AU - Australia 29
ZA - Sudafrica 28
PT - Portogallo 27
AT - Austria 25
IQ - Iraq 25
SA - Arabia Saudita 25
UZ - Uzbekistan 23
PK - Pakistan 21
EC - Ecuador 18
PE - Perù 17
NO - Norvegia 15
CL - Cile 13
CZ - Repubblica Ceca 13
JO - Giordania 12
RO - Romania 12
KE - Kenya 10
LT - Lituania 10
PY - Paraguay 10
VE - Venezuela 10
BA - Bosnia-Erzegovina 9
IL - Israele 9
IR - Iran 9
MA - Marocco 9
TN - Tunisia 9
CR - Costa Rica 8
HU - Ungheria 8
RS - Serbia 8
UY - Uruguay 8
AL - Albania 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
EG - Egitto 6
HR - Croazia 6
LU - Lussemburgo 6
OM - Oman 6
SC - Seychelles 6
SK - Slovacchia (Repubblica Slovacca) 6
AZ - Azerbaigian 5
CU - Cuba 5
ET - Etiopia 5
JM - Giamaica 5
KW - Kuwait 5
MY - Malesia 5
TH - Thailandia 5
BG - Bulgaria 4
DZ - Algeria 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
QA - Qatar 4
BH - Bahrain 3
GE - Georgia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BS - Bahamas 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
KG - Kirghizistan 2
Totale 20.970
Salva come PNG Salva come JPEG
Città #
Southend 1.307
Singapore 1.213
Ashburn 662
Hong Kong 546
Chandler 536
San Jose 390
Beijing 385
Hanover 374
Milan 359
Dallas 321
Seattle 238
Princeton 217
Council Bluffs 206
Shanghai 206
Wilmington 191
Munich 182
Los Angeles 179
Santa Clara 176
Dublin 167
Fairfield 154
Ann Arbor 145
Hangzhou 144
New York 139
Frankfurt am Main 133
Lauterbourg 110
Montréal 110
Dearborn 109
Nanjing 108
Toronto 101
Ho Chi Minh City 96
Bengaluru 91
Guangzhou 91
Woodbridge 91
Mcallen 87
Houston 81
Moscow 80
Phoenix 80
Buffalo 77
Hanoi 76
Tokyo 74
Des Moines 70
Redmond 70
Jacksonville 68
Hefei 66
Mountain View 66
Helsinki 65
Grafing 63
Cambridge 58
Madrid 56
The Dalles 56
Redwood City 54
Granada 51
Jakarta 50
Rome 50
Boardman 49
Abidjan 47
Sakarya 47
Columbus 46
Suzhou 46
Seoul 45
São Paulo 45
Bogotá 43
Serra 42
Jinan 41
Somerville 41
Brussels 40
Barcelona 39
Dong Ket 39
Berlin 37
Cangzhou 36
Andover 35
Chicago 35
Tianjin 34
Warsaw 34
Changsha 31
Shenzhen 31
Athens 28
Paris 28
Zhengzhou 28
Bologna 27
Córdoba 27
Shenyang 27
Turin 27
Falls Church 25
Istanbul 25
Sunnyvale 25
Brooklyn 24
Naples 23
Hebei 22
Washington 22
Hamburg 21
Da Nang 20
Fremont 20
London 20
San Diego 20
Nuremberg 19
Eitensheim 18
Mumbai 18
Ottawa 18
Rio de Janeiro 18
Totale 12.308
Salva come PNG Salva come JPEG
Nome #
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases 2.270
Role of epigenetic therapy in the modulation of tumor growth and migration in human castration-resistant prostate cancer cells with neuroendocrine differentiation 666
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications 533
Complement activation in anti-phospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery 493
Effetti a lungo termine degli analoghi della somatostatina in linee cellulari di tumori ipofisari GH-secernenti. 438
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells 339
Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts 338
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 323
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 313
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 308
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome 288
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers 274
L’aumento del drive simpatico che si osserva durante bypass aortocoronarico correla con l’espressione delle citochine proinfiammatorie ed é attenuato dalla terapia betabloccante 270
8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms 268
Histone deacetylase inhibitors ameliorate morphological defects and hypoexcitability of iPSC-neurons from Rubinstein-Taybi patients 241
Vandetanib versus cabozantinib in medullary thyroid carcinoma: A focus on anti‐angiogenic effects in zebrafish model 240
Protective effect of a synthetic peptide mimicking the b2GPI PL-binding site on aPL-induced placental damage 237
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 231
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination 221
Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation 220
Patients with antiphospholipid syndrome display endothelial perturbation 214
Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss 209
TLR-4 and Annexin A2 Involvement in endothelial cell activation by anti-phospholipid antibodies : specific silencing by small interfering RNAs 209
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts 208
Antiphospholipid antibodies and ex-vivo endothelial perturbation 203
Antiphospholipid antibodies and the antiphospholipid syndrome : pathogenic mechanisms 202
Association between clinical features and inflammatory gene SNPs in APS 202
Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer 199
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 198
Mechanisms of action of antiphospholipid antibodies 198
Toll-like receptors : another player in the pathogenesis of the anti-phospholipid sindrome 193
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers 191
Anti-phospholipid antibody mediated fetal loss : still an open question from a pathogenic point of view 191
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies 190
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5 : ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome 181
Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation 180
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies 176
Antibodies Against Domain 1 and Domain 4/5 of β2 Glycoprotein I : Clinical Relevance in Obstetric Anti-Phospholipid Syndrome 174
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy 171
Anti-NR2 antibodies and primary antiphospholipid syndrome : a preliminary study 170
Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. 169
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 169
Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus 168
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer 165
Effect of TNFalpha blocking agents on mRNA and miRNA profile in RA patients 165
Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement 164
8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth 163
Efficacy of a novel second-generation somatostatin-dopamine chimera (TBR-065) in human medullary thyroid cancer: a preclinical study 162
Pathogenesis of antiphospholipid syndrome : understanding the antibodies 160
Toll-like receptor and antiphospholipid mediated thrombosis : in vivo studies 158
Effects of human recombinant type I IFNs (IFN-α2b and IFN-β1a) on growth and migration of primary endometrial stromal cells from women with deeply infiltrating endometriosis : a preliminary study 156
Interferon-inducible genes, TNF-related apoptosis-inducing ligand (TRAIL) and interferon inducible protein 27 (IFI27) are negatively regulated in leiomyomas: implications for a role of the interferon pathway in leiomyoma development 155
Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients 153
Primary Antiphospholipid Syndrome Patients Display Increased Levels of Cell-Bound C4d in Comparison to SLE and Healthy Donors 152
Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block : lesson from twins and triplets discordant for the disease 150
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 150
TLR-4 and Annexin A2 involvement in pathogenic effects induced by anti-phospholipid antibodies is demonstrated by specific blocking agents and small interfering RNA in human endothelial cells 149
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy 149
Immune parameters identify Italian centenarians with a longer five-year survival independent of their health and functional status 148
Antiphospholipid syndrome: not only an antibody-mediated disease 144
Endothelium activation in the anti-phospholipid syndrome 142
Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells 142
Early endothelial damage in patients with raynaud's phenomenon 142
Relationship between sle susceptibility genes and clinical manifestations in a cohort of patients with primary antiphospholipid syndrome 140
Chemerin serum levels in systemic sclerosis: a novel marker of early and active disease? 140
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis 140
Empirical Approach to Investigate Raynaud's Phenomenon : the Pearl Study : AB1085  139
Humoral autoimmunity against endothelium : theory or reality? 138
Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome 137
Exploring the multifaceted antitumor activity of axitinib in lung carcinoids 135
Differential impairment of serum cholesterol efflux capacity in patients with rheumatoid arthritis and systemic lupus erythematosus 135
Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies. 134
Role of anti-beta(2) glycoprotein I antibodies in anti phospholipid syndrome : In vitro and in vivo studies 130
Anti-fibroblast antibodies in systemic sclerosis 130
Innate immunity in the antiphospholipid syndrome : role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies 129
Endothelial cell activation by antiphospholipid antibodies 129
Targeting of fibroblast growth factor receptor pathway as a new anti-tumor strategy for medullary thyroid cancer 128
Obstetric and vascular antiphospholipid syndrome: Same antibodies but different diseases? 128
Enhanced liver fibrosis test: a further step toward depiction of fibrotic process in very early diagnosis of systemic sclerosis 127
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis 126
Complement activation in anti-phospholipid syndrome : a clue for an inflammatory process? 126
Obstetric and vascular APS : same autoantibodies but different diseases? 124
Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series 124
Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro 124
Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study 123
In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants. 119
The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines 119
Serum chemerin in systemic sclerosis : a novel marker of early diffuse disease? 118
Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies 117
Antibodies and Diagnostic Tests in Antiphospholipid Syndrome 116
Update on the pathogenesis and treatment of the antiphospholipid syndrome 111
Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies 110
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis 110
Mechanisms of Action of the Antiphospholipid Antibodies 110
The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease 109
Vitamin D and anti-phospholipid antibody syndrome : A comprehensive review 109
European forum on antiphospholipid antibodies : research in progress 108
Standardization of autoantibody testing : a paradigm for serology in rheumatic diseases 108
The challenges of lupus anticoagulants 106
Improvement of lipoprotein functions related to cell cholesterol trafficking in rheumatoid arthritis patients treated with tocilizumab 105
Totale 20.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021383 0 0 0 0 0 0 0 0 0 0 237 146
2021/20221.938 146 111 91 106 131 126 201 163 241 194 140 288
2022/20232.157 262 262 177 244 165 344 65 125 201 81 132 99
2023/20241.500 70 119 126 123 339 114 51 99 43 99 141 176
2024/20253.425 110 349 97 334 273 151 185 301 222 304 296 803
2025/20266.896 660 440 733 637 832 462 804 414 638 574 702 0
Totale 21.830